Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
127.75
-1.59 (-1.23%)
At close: Aug 7, 2025, 4:00 PM
128.01
+0.26 (0.20%)
After-hours: Aug 7, 2025, 7:53 PM EDT

Biogen Revenue

Biogen had revenue of $2.65B in the quarter ending June 30, 2025, with 7.33% growth. This brings the company's revenue in the last twelve months to $10.00B, up 3.36% year-over-year. In the year 2024, Biogen had annual revenue of $9.68B, down -1.62%.

Revenue (ttm)
$10.00B
Revenue Growth
+3.36%
P/S Ratio
1.87
Revenue / Employee
$1,314,530
Employees
7,605
Market Cap
18.73B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.68B-159.70M-1.62%
Dec 31, 20239.84B-337.80M-3.32%
Dec 31, 202210.17B-808.30M-7.36%
Dec 31, 202110.98B-2.46B-18.32%
Dec 31, 202013.44B-933.30M-6.49%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.